Breakdown of antimicrobial host defense barrier as trigger of chronic inflammatory bowel diseases

Breakdown of antimicrobial host defense barrier as trigger of chronic inflammatory bowel diseases

Bibliographic Details
Main Author:	Wehkamp Jan
Format:	Article
Language:	English
Published:	BMC 2011-11-01
Series:	Journal of Translational Medicine

Similar Items

Role of Antimicrobial Peptides in Inflammatory Bowel Disease
by: Stefan Vordenbäumen, et al.
Published: (2011-11-01)

Defense mechanisms and alexithymia in Inflammatory bowel disease and Irritable bowel disease
by: Vittorio Lenzo, et al.
Published: (2019-04-01)

Quality of life in inflammatory bowel diseases: it is not all about the bowel
by: Ronald Keller, et al.
Published: (2021-01-01)

Practical guidance for the management of iron deficiency in patients with inflammatory bowel disease
by: Dorothea Niepel, et al.
Published: (2018-04-01)

Antimicrobial Proteins in Intestine and Inflammatory Bowel Diseases
by: Jung Mogg Kim
Published: (2014-01-01)

Inflammatory bowel diseases: Microbiota versus the barrier
by: Devendra Desai
Published: (2015-01-01)

Stress Triggers Flare of Inflammatory Bowel Disease in Children and Adults
by: Yue Sun, et al.
Published: (2019-10-01)

Biologic therapies for chronic inflammatory bowel disease
by: M. P. Martínez-Montiel, et al.

Bronchopulmonary lesions in chronic inflammatory bowel diseases
by: Zyfa Fyaskhetdinovna Mikhaylova, et al.
Published: (2010-03-01)

Immunological studies in chronic inflammatory bowel disease
by: Johnson, Norman McIntosh
Published: (1977)

Inflammatory Bowel Diseases: Host-Microbial-Environmental Interactions in Dysbiosis
by: Catherine Colquhoun, et al.
Published: (2020-05-01)

Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel Disease
by: Michael Stürzl, et al.
Published: (2021-08-01)

Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases
by: Jessica Y. Lee, et al.
Published: (2018-03-01)

Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease
by: Jing Sun, et al.
Published: (2016-01-01)

Cathelicidins—Therapeutic antimicrobial and antitumor host defense peptides for oral diseases
by: Kazuhiko Okumura
Published: (2011-02-01)

Antimicrobial peptides of buffalo and their role in host defenses
by: Khangembam Victoria Chanu, et al.
Published: (2018-02-01)

Host gene–microbiome interactions: molecular mechanisms in inflammatory bowel disease
by: Hiutung Chu
Published: (2017-07-01)

Barriers to clinical research in children with inflammatory bowel disease: The patients' perspective.
by: Wael El-Matary, et al.
Published: (2018-01-01)

Microbiota-Host Symbiosis In First-Onset Pediatric Inflammatory Bowel Disease
by: Mottawea, Walid Abd El-Fattah El-Sayed
Published: (2015)

COPING STRATEGIES OF PATIENTS WITH CHRONIC INFLAMMATORY BOWEL DISEASES
by: A. Ye. Baksht, et al.
Published: (2013-12-01)

Chronic inflammatory bowel diseases: epidemiological features in Ukraine
by: Yu.M. Stepanov, et al.
Published: (2017-04-01)

The role of biomarkers in the diagnostics of chronic inflammatory bowel diseases
by: Yu.M. Stepanov, et al.
Published: (2017-02-01)

Diagnosis of chronic inflammatory bowel disease - a dilemma
by: M.E. Kisansa
Published: (2004-06-01)

Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes.
by: Fumitaka Shimizu, et al.
Published: (2014-01-01)

The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010-01-01)

CD147 Aggravated Inflammatory Bowel Disease by Triggering NF-κB-Mediated Pyroptosis
by: Zhaohui Xu, et al.
Published: (2020-01-01)

Monocarboxylate Transporter 4 Triggered Cell Pyroptosis to Aggravate Intestinal Inflammation in Inflammatory Bowel Disease
by: Yaodong Wang, et al.
Published: (2021-05-01)

Expression of human beta-defensins in children with chronic inflammatory bowel disease.
by: Matthias Zilbauer, et al.
Published: (2010-01-01)

Effect of Vedolizumab on Anemia of Chronic Disease in Patients with Inflammatory Bowel Diseases
by: Patrizio Scarozza, et al.
Published: (2020-07-01)

Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease
by: April L. Raftery, et al.
Published: (2020-09-01)

Epithelial antimicrobial peptides in host defense against infection
by: Bals Robert
Published: (2000-10-01)

Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease
by: F. J. Ryan, et al.
Published: (2020-03-01)

Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases
by: Heather Armstrong, et al.
Published: (2019-01-01)

Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease
by: Ming Zhang, et al.
Published: (2017-08-01)

Metabolic Host–Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD)
by: Alexander S. Dowdell, et al.
Published: (2021-07-01)

Procoagulatory State in Inflammatory Bowel Diseases Is Promoted by Impaired Intestinal Barrier Function
by: Luca Pastorelli, et al.
Published: (2015-01-01)

Host defense triggers rapid adaptive radiation in experimentally evolving parasites
by: Sarah E. Bush, et al.
Published: (2019-04-01)

Absorptive function of the small intestine at chronic inflammatory bowel diseases
by: V. A. Burkovskaya, et al.
Published: (2009-08-01)

Lifestyle Issues in Children and Adolescents with Chronic Inflammatory Bowel Diseases
by: P Sherman, et al.
Published: (1990-01-01)

The local immunity of the mouth of persons with chronic inflammatory bowel disease
by: S. Yu. Tytyuk, et al.
Published: (2015-08-01)